Dimoveo Medical
Pioneering internal body cavity disinfection for implants, eliminating the need for removal.
Pioneering internal body cavity disinfection for implants, eliminating the need for removal.
Dimoveo Medical is pioneering the development of internal body cavity disinfection technologies for implants, aiming to eliminate the need for removing implants from the body. The company, founded in 2020, operates in the Biotechnology and Health Care industries. In October 2020, MEDX Xelerator made a significant $800.00K Pre Seed Round investment in Dimoveo Medical, demonstrating confidence in the company's innovative approach to internal body cavity disinfection. This investment reflects the growing interest in healthcare technologies that can improve patient outcomes and reduce the need for invasive procedures. Dimoveo Medical's focus on developing solutions that can potentially revolutionize implant procedures aligns with current industry trends and the increasing demand for advanced medical technologies. As the company continues to advance its disinfection technologies, it has the potential to make a significant impact in the field of medical implants and patient care.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Pre Seed Round | $800.00K | 1 | MEDX Xelerator | 26 Oct 2020 |
No recent news or press coverage available for Dimoveo Medical.
We care about your data, and we'd love to use cookies make your experience better.
